Reduction of amyloid angiopathy and Aβ plaque burden after enriched housing in TgCRND8 mice: Involvement of multiple pathways

American Journal of Pathology

Volumn 169, Issue 2, 2006, Pages 544-552

  Ambrée, Oliver ^a,b   Leimer, Uwe ^a   Herring, Arne ^a   Görtz, Nicole ^b   Sachser, Norbert ^b   Heneka, Michael T ^a   Paulus, Werner ^a   Keyvani, Kathy ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; CHOLESTEROL; PROTEASOME;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DNA MICROARRAY; ENVIRONMENTAL FACTOR; FEMALE; GENE CONTROL; IMMUNOBLOTTING; INTELLIGENCE; LIFESTYLE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

EID: 33746633882     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051107     Document Type: Article

References (48)

1. Mattson M: Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639
2. Finkel SI: Behavioral and psychological symptoms of dementia. Clin Geriatr Med 2003, 19:799-824
3. Ritchie K, Lovestone S: The dementias. Lancet 2002, 360:1759-1766
4. Friedland RP, Fritsch T, Smyth KA, Koss E, Lerner AJ, Chen CH, Petot GJ, Debanne SM: Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci USA 2001, 98:3440-3445
5. Wilson RS, Mendes De Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, Bennett DA: Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 2002, 287:742-748
6. van Praag H, Kempermann G, Gage FH: Neural consequences of environmental enrichment. Nat Rev Neurosci 2000, 1:191-198
7. Marashi V, Barnekow A, Ossendorf E, Sachser N: Effects of different forms of environmental enrichment on behavioral, endocrinological, and immunological parameters in male mice. Horm Behav 2003, 43:281-292
8. Johansson BB, Belichenko PV: Neuronal plasticity and dendritic spines: effect of environmental enrichment on intact and postischemic rat brain. J Cereb Blood Flow Metab 2002, 22:89-96
9. Keyvani K, Sachser N, Witte OW, Paulus W: Gene expression profiling in the intact and injured brain following environmental enrichment. J Neuropathol Exp Neurol 2004, 63:598-609
10. van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ: Delaying the onset of Huntington's in mice. Nature 2000, 404:721-722
11. Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ: Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Brain Res Mol Brain Res 2005, 134:170-179
12. Arendash G, Garcia M, Costa D, Cracchiolo J, Wefes I, Potter H: Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 2004, 15:1751-1754
13. Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, Younkin LH, Younkin SG, Borchelt DR, Savonenko AV: Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci 2005, 25:5217-5224
14. Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR: Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 2003, 62:1220-1227
15. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VMY, Hersh LB, Sapolsky RM, Mimics K, Sisodia SS: Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005, 120:701-713
16. Adlard PA, Perreau VM, Pop V, Cotman CW: Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 2005, 25:4217-4221
17. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, St. George-Hyslop P, Westaway D: Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 2001, 276:21562-21570
18. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Home P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St. George-Hyslop P, Westaway D: Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000, 408:979-982
19. Klafki HW, Wiltfang J, Staufenbiel M: Electrophoretic separation of betaA4 peptides (1-40) and (1-42). Anal Biochem 1996, 237:24-29
20. Schägger H, von Jagow G: Tricine-sodium dodecyl sulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987, 166:368-379
21. Kaiser S, Kirtzeck M, Hornschuh G, Sachser N: Sex-specific difference in social support-a study in female guinea pigs. Physiol Behav 79:297-303
22. Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981, 11:805-815
23. Masters C, Beyreuther K: Molecular pathogenesis of Alzheimer's disease. The Molecular Pathology of Dementia and Movement Disorders. Edited by Dickson D. Basel, ISN Neuropathology Press, 2003, pp 69-73
24. Yamamoto M, Horiba M, Buescher JL, Huang D, Gendelman HE, Ransohoff RM, Ikezu T: Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition. Am J Pathol 2005, 166:1475-1485
25. Regan JW: EP2 and EP4 prostanoid receptor signaling. Life Sci 2003, 74:143-153
26. Mott RT, Ait-Ghezala G, Town T, Mori T, Vendrame M, Zeng J, Ehrhart J, Mullan M, Tan J: Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 2004, 46:369-379
27. Bourdeau A, Dube N, Tremblay ML: Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr Opin Cell Biol 2005, 17:203-209
28. Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B: How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 2004, 3:169-176
29. Shie FS, Breyer RM, Montine TJ: Microglia lacking E prostanoid receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity. Am J Pathol 2005, 166:1163-1172
30. Shie FS, Montine KS, Breyer RM, Montine TJ: Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons. Brain Pathol 2005, 15:134-138
31. Ehninger D, Kempermann G: Regional effects of wheel running and environmental enrichment on cell genesis and microglia proliferation in the adult murine neocortex. Cereb Cortex 2003, 13:845-851
32. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T: Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000, 6:916-919
33. DiCarlo G, Wilcock D, Henderson D, Gordon M, Morgan D: Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiol Aging 2001, 22:1007-1012
34. Bacskai BJ, Kajdasz ST, Christie RH, Carter C, Games D, Seubert P, Schenk D, Hyman BT: Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med 2001, 7:369-372
35. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S: Bone marrow-derived mioroglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006, 49:489-502
36. Wyss-Coray T, Mucke L: Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002, 35:419-432
37. Rogers J, Strohmeyer R, Kovelowski CJ, Li R: Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 2002, 40:260-269
38. Ciechanover A, Brundin P: The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 2003, 40:427-446
39. Keller JN, Hanni KB, Markesbery WR: Impaired proteasome function in Alzheimer's disease. J Neurochem 2000, 75:436-439
40. Lopez Salon M, Pasquini L, Besio Moreno M, Pasquini JM, Soto E: Relationship between beta-amyloid degradation and the 26S proteasome in neural cells. Exp Neurol 2003, 180:131-143
41. Reiss AB, Siller KA, Rahman MM, Chan ESL, Ghiso J, de Leon MJ: Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiol Aging 2004, 25:977-989
42. Puglielli L, Tanzi RE, Kovacs DM: Alzheimer's disease: the cholesterol connection. Nat Neurosci 2003, 6:345-351
43. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA: Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000, 7:321-331
44. Zhang Q, Powers ET, Nieva J, Huff ME, Dendle MA, Bieschke J, Glabe CG, Eschenmoser A, Wentworth PJ, Lerner RA, Kelly JW: Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc Natl Acad Sci USA 2004, 101:4752-4757
45. Assanasen C, Mineo C, Seetharam D, Yuhanna IS, Marcel YL, Connelly MA, Williams DL, de la Llera-Moya M, Shaul PW, Silver DL: Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J Clin Invest 2005, 115:969-977
46. Elias PM, Crumrine D, Rassner U, Hachem JP, Menon GK, Man W, Choy MHW, Leypoldt L, Feingold KR, Williams ML: Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 2004, 122:314-319
47. Zlokovic BV: Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 2005, 28:202-208
48. Attems J: Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol (Berl) 2005, 110:345-359